304 related articles for article (PubMed ID: 34324983)
1. Cannabidiol loaded extracellular vesicles sensitize triple-negative breast cancer to doxorubicin in both in-vitro and in vivo models.
Patel N; Kommineni N; Surapaneni SK; Kalvala A; Yaun X; Gebeyehu A; Arthur P; Duke LC; York SB; Bagde A; Meckes DG; Singh M
Int J Pharm; 2021 Sep; 607():120943. PubMed ID: 34324983
[TBL] [Abstract][Full Text] [Related]
2. Macrophage-Derived Extracellular Vesicles as Drug Delivery Systems for Triple Negative Breast Cancer (TNBC) Therapy.
Haney MJ; Zhao Y; Jin YS; Li SM; Bago JR; Klyachko NL; Kabanov AV; Batrakova EV
J Neuroimmune Pharmacol; 2020 Sep; 15(3):487-500. PubMed ID: 31722094
[TBL] [Abstract][Full Text] [Related]
3. Anticancer and chemosensitization effects of cannabidiol in 2D and 3D cultures of TNBC: involvement of GADD45α, integrin-α5, -β5, -β1, and autophagy.
Surapaneni SK; Patel N; Sun L; Kommineni N; Kalvala AK; Gebeyehu A; Arthur P; Duke LC; Nimma R; G Meckes D; Singh M
Drug Deliv Transl Res; 2022 Nov; 12(11):2762-2777. PubMed ID: 35217991
[TBL] [Abstract][Full Text] [Related]
4. Platelet extracellular vesicles are efficient delivery vehicles of doxorubicin, an anti-cancer drug: preparation and in vitro characterization.
Wu YW; Lee DY; Lu YL; Delila L; Nebie O; Barro L; Changou CA; Lu LS; Goubran H; Burnouf T
Platelets; 2023 Dec; 34(1):2237134. PubMed ID: 37580876
[TBL] [Abstract][Full Text] [Related]
5. Cannabidiol-Loaded Extracellular Vesicles from Human Umbilical Cord Mesenchymal Stem Cells Alleviate Paclitaxel-Induced Peripheral Neuropathy.
Kalvala AK; Bagde A; Arthur P; Kulkarni T; Bhattacharya S; Surapaneni S; Patel NK; Nimma R; Gebeyehu A; Kommineni N; Meckes DG; Sun L; Banjara B; Mosley-Kellum K; Dinh TC; Singh M
Pharmaceutics; 2023 Feb; 15(2):. PubMed ID: 36839877
[TBL] [Abstract][Full Text] [Related]
6. CBD loaded microparticles as a potential formulation to improve paclitaxel and doxorubicin-based chemotherapy in breast cancer.
Fraguas-Sánchez AI; Fernández-Carballido A; Simancas-Herbada R; Martin-Sabroso C; Torres-Suárez AI
Int J Pharm; 2020 Jan; 574():118916. PubMed ID: 31811927
[TBL] [Abstract][Full Text] [Related]
7. The role of Cannabidiol and tetrahydrocannabivarin to overcome doxorubicin resistance in MDA-MB-231 xenografts in athymic nude mice.
Kalvala AK; Nimma R; Bagde A; Surapaneni SK; Patel N; Arthur P; Sun L; Singh R; Kommineni N; Nathani A; Li Y; Singh M
Biochimie; 2023 May; 208():19-30. PubMed ID: 36535544
[TBL] [Abstract][Full Text] [Related]
8. Extracellular vesicles derived from dendritic cells loaded with VEGF-A siRNA and doxorubicin reduce glioma angiogenesis in vitro.
Shamshiripour P; Rahnama M; Nikoobakht M; Rad VF; Moradi AR; Ahmadvand D
J Control Release; 2024 May; 369():128-145. PubMed ID: 38522817
[TBL] [Abstract][Full Text] [Related]
9. α-Tocopherol Polyethylene Glycol 1000 Succinate-Based Cationic Liposome for the Intracellular Delivery of Doxorubicin in MDA-MB-231 Triple-Negative Breast Cancer Cell Line.
Sandal P; Patel P; Singh D; Gupta GD; Kurmi BD
Assay Drug Dev Technol; 2023; 21(8):345-356. PubMed ID: 38010987
[No Abstract] [Full Text] [Related]
10. Extracellular vesicles from triple-negative breast cancer cells promote proliferation and drug resistance in non-tumorigenic breast cells.
Ozawa PMM; Alkhilaiwi F; Cavalli IJ; Malheiros D; de Souza Fonseca Ribeiro EM; Cavalli LR
Breast Cancer Res Treat; 2018 Dec; 172(3):713-723. PubMed ID: 30173296
[TBL] [Abstract][Full Text] [Related]
11. Synergistic Interactions of Cannabidiol with Chemotherapeutic Drugs in MCF7 Cells: Mode of Interaction and Proteomics Analysis of Mechanisms.
Alsherbiny MA; Bhuyan DJ; Low MN; Chang D; Li CG
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34576262
[TBL] [Abstract][Full Text] [Related]
12. Combination Treatment with EGFR Inhibitor and Doxorubicin Synergistically Inhibits Proliferation of MCF-7 Cells and MDA-MB-231 Triple-Negative Breast Cancer Cells In Vitro.
Abrahams B; Gerber A; Hiss DC
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474312
[TBL] [Abstract][Full Text] [Related]
13. Extracellular vesicles of cannabis with high CBD content induce anticancer signaling in human hepatocellular carcinoma.
Tajik T; Baghaei K; Moghadam VE; Farrokhi N; Salami SA
Biomed Pharmacother; 2022 Aug; 152():113209. PubMed ID: 35667235
[TBL] [Abstract][Full Text] [Related]
14. Cannabidiol Antiproliferative Effect in Triple-Negative Breast Cancer MDA-MB-231 Cells Is Modulated by Its Physical State and by IGF-1.
D'Aloia A; Ceriani M; Tisi R; Stucchi S; Sacco E; Costa B
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806150
[TBL] [Abstract][Full Text] [Related]
15. Single-particle assessment of six different drug-loading strategies for incorporating doxorubicin into small extracellular vesicles.
Chen C; Li Y; Wang Q; Cai N; Wu L; Yan X
Anal Bioanal Chem; 2023 Mar; 415(7):1287-1298. PubMed ID: 35945289
[TBL] [Abstract][Full Text] [Related]
16. Modulation of the tumor microenvironment and inhibition of EGF/EGFR pathway: novel anti-tumor mechanisms of Cannabidiol in breast cancer.
Elbaz M; Nasser MW; Ravi J; Wani NA; Ahirwar DK; Zhao H; Oghumu S; Satoskar AR; Shilo K; Carson WE; Ganju RK
Mol Oncol; 2015 Apr; 9(4):906-19. PubMed ID: 25660577
[TBL] [Abstract][Full Text] [Related]
17. Circulating extracellular vesicles from patients with breast cancer enhance migration and invasion via a Src‑dependent pathway in MDA‑MB‑231 breast cancer cells.
Ramírez-Ricardo J; Leal-Orta E; Martínez-Baeza E; Ortiz-Mendoza C; Breton-Mora F; Herrera-Torres A; Elizalde-Acosta I; Cortes-Reynosa P; Thompson-Bonilla R; Perez Salazar E
Mol Med Rep; 2020 Sep; 22(3):1932-1948. PubMed ID: 32582965
[TBL] [Abstract][Full Text] [Related]
18. The synergistic anticancer effect of CBD and DOX in osteosarcoma.
Li J; Jiang W; Shan W; Luo A; Qu G; Zhang J; Luo X; Xia J
Clin Transl Oncol; 2023 Aug; 25(8):2408-2418. PubMed ID: 36848028
[TBL] [Abstract][Full Text] [Related]
19. Extracellular Vesicles Derived From Human Umbilical Cord Mesenchymal Stem Cells Protect Against DOX-Induced Heart Failure Through the miR-100-5p/NOX4 Pathway.
Zhong Z; Tian Y; Luo X; Zou J; Wu L; Tian J
Front Bioeng Biotechnol; 2021; 9():703241. PubMed ID: 34513812
[TBL] [Abstract][Full Text] [Related]
20. Amplification of anticancer efficacy by co-delivery of doxorubicin and lonidamine with extracellular vesicles.
Li H; Xu W; Li F; Zeng R; Zhang X; Wang X; Zhao S; Weng J; Li Z; Sun L
Drug Deliv; 2022 Dec; 29(1):192-202. PubMed ID: 34984953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
